[{"AccountsPayableCurrent_0_Q2_USD":24759000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-51000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":13000000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":17000000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":800000000.0,"PaymentsForRestructuring_2_Q2_USD":34000000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":289000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-24000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":141000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"ProfitLoss_1_Q2_USD":49000000.0,"ProfitLoss_2_Q2_USD":321000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2321000000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":25000000.0,"ReceivablesNetCurrent_0_Q2_USD":9406000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":500000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":592000000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-51000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-43000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":815000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":549000000.0,"NetIncomeLoss_1_Q2_USD":49000000.0,"NetIncomeLoss_2_Q2_USD":320000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":1000000.0,"NumberOfOperatingSegments_2_Q2_segment":2.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-24000000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"OperatingIncomeLoss_2_Q2_USD":-535000000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2669000000.0,"OtherAssetsCurrent_0_Q2_USD":4339000000.0,"OtherAssetsNoncurrent_0_Q2_USD":913000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":-6000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":-8000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-18000000.0,"OperatingIncomeLoss_1_Q2_USD":-950000000.0,"RestructuringCharges_1_Q2_USD":7000000.0,"RestructuringCharges_2_Q2_USD":25000000.0,"RestructuringCosts_2_Q2_USD":17000000.0,"StockholdersEquityOther_2_Q2_USD":0.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_2_Q2_shares":1000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":19000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":18000000.0,"TreasuryStockShares_0_Q2_shares":50000000.0,"TreasuryStockValue_0_Q2_USD":2883000000.0,"StockholdersEquityOther_1_Q2_USD":1000000.0,"TreasuryStockValueAcquiredCostMethod_1_Q2_USD":300000000.0,"UnrecognizedTaxBenefits_0_Q2_USD":937000000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":45000000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":854000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":2000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":2000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":281000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":285000000.0,"TreasuryStockValueAcquiredCostMethod_2_Q2_USD":800000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":1002000000.0,"StockholdersEquity_0_Q2_USD":998000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"RestructuringReserve_0_Q2_USD":62000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":1245000000.0,"Revenues_1_Q2_USD":45457000000.0,"Revenues_2_Q2_USD":89425000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":1151000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":2265000000.0,"SeveranceCosts1_1_Q2_USD":2000000.0,"SeveranceCosts1_2_Q2_USD":10000000.0,"ShareBasedCompensation_2_Q2_USD":42000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":69.41,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":69.24,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-1708000000.0,"MinorityInterest_0_Q2_USD":4000000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q2_USD":301000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":5342000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":25000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":270000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":43841000000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":86167000000.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q2_USD":9607000000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":332000000.0,"Dividends_1_Q2_USD":139000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":269000000.0,"Dividends_2_Q2_USD":280000000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":1.531,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-11000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":2000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":6000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":2974000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":286000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":157000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":1.05,"ComprehensiveIncomeNetOfTax_1_Q2_USD":25000000.0,"CommonStockValue_0_Q2_USD":2721000000.0,"CommonStockSharesIssued_0_Q2_shares":327000000.0,"AccountsPayableCurrentAndNoncurrent_0_Q2_USD":24800000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-85000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":42000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":18000000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":79000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":157000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":5000000.0,"Assets_0_Q2_USD":43680000000.0,"AssetsCurrent_0_Q2_USD":31847000000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperation_0_Q2_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":3161000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-246000000.0,"ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_1_Q2_USD":0.0,"ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_2_Q2_USD":0.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.4908,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.9816,"CommonStockSharesAuthorized_0_Q2_shares":755000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":210000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":279000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":237000000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":4905000000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-1022000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-925000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1059000000.0,"IncreaseDecreaseInInventories_2_Q2_USD":361000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":1842000000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":329000000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":12000000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":1.12,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":4917000000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":8599000000.0,"InterestExpense_1_Q2_USD":37000000.0,"InterestExpense_2_Q2_USD":77000000.0,"InventoryNet_0_Q2_USD":14941000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":43680000000.0,"LiabilitiesCurrent_0_Q2_USD":27729000000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0_Q2_USD":0.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":1943000000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":0.17,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":1.13,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":0.17,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":1931000000.0,"GainLossOnSaleOfInvestments_1_Q2_USD":1000000.0,"GainLossOnSaleOfInvestments_2_Q2_USD":1000000.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_1_Q2_USD":-1295000000.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_2_Q2_USD":-1293000000.0,"GainLossRelatedToLitigationSettlement_1_Q2_USD":-34000000.0,"GainLossRelatedToLitigationSettlement_2_Q2_USD":-52000000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-10000000.0,"Goodwill_0_Q2_USD":6656000000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":0.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-26000000.0,"GoodwillImpairmentLoss_2_Q2_USD":1307000000.0,"GrossProfit_1_Q2_USD":1616000000.0,"GrossProfit_2_Q2_USD":3258000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-973000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-604000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":262000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":283000000.0,"Ticker":"CAH","CIK":"721371","name":"CARDINAL HEALTH INC","OfficialName":"Cardinal Health Inc. Common Stock","form":"10-Q","period":"20211231","fy":"2022.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17377290506.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20220203"}]